Navigation Links
CEO Addresses Fort Worth Business Leaders About Developing Pandemic and Business Continuity Plans
Date:5/16/2008

FORT WORTH, Texas, May 16 /PRNewswire/ -- George Abercrombie, president and chief executive officer, Hoffmann-La Roche Inc., told more than 200 Fort Worth business leaders today at a Rotary Club of Fort Worth luncheon that the threat of a pandemic flu presents businesses with challenges unlike those anticipated with traditional emergency preparedness plans.

"While businesses are all too familiar with preparing for potential disasters such as floods or tornadoes," according to Abercrombie, "local businesses also need to look at the special challenges posed by the potential of a public health crisis caused by a global influenza pandemic."

Abercrombie, who shared details of Roche's own plans to safeguard the health of its employees and business infrastructure during a pandemic flu outbreak, says that Texas's key industry sectors, including technology, aerospace and defense, manufacturing, biotechnology and life sciences, energy, petroleum refinery and chemical products, healthcare, real estate, finance, construction, real estate, and hospitality and food service would be among the hardest hit.

In March of 2007, Trust for America's Health released a report (funded by The Pew Charitable Trusts as part of the U.S. Pandemic Preparedness Initiative) estimating that Texas could face a potential financial loss of $55.8 billion as a result of a severe pandemic flu outbreak.

"Influenza pandemics are not static events like a hurricane or tornado, nor are they confined to a specific area. Pandemics come in multiple waves, each one affecting a given area from four to twelve weeks. During the first wave, officials expect 20 to 30% of people will become ill. Here in Tarrant County, that's 334,000 to 500,000 people who will get very sick in a very short period of time, inundating emergency rooms already strained to near capacity."

According to Abercrombie, experts believe that many businesses and organizations would have difficulty maintaining operations as a result of an increased level of absenteeism due to illness, employees caring for the sick and social-distancing policies. In Texas alone, there is the potential for more than 6.7 million employees to be absent from their jobs, according to the Trust for America's Health report, resulting in losses of roughly $23.6 billion dollars due to absenteeism and death.

Based on his experience in working with the federal government the past several years on pandemic preparedness, Abercrombie reminded the audience that the government has asked private businesses to share in the responsibility of planning. While the federal government has plans to help slow the spread of the virus among critical populations, such as healthcare workers and emergency personnel, it is up to local communities and businesses to ensure that residents and employees stay healthy and that businesses and local economies remain up and running.

More information on how businesses can organize their own pandemic plans is available online at http://www.pandemictoolkit.com. For more information about the Trust for America's Health, visit http://healthyamericans.org/reports/flurecession/releases/TN.pdf.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or http://www.roche.us.

All trademarks used or mentioned in this release are protected by law.


'/>"/>
SOURCE Hoffmann-La Roche Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Publication Addresses Misconceptions About Emergency Contraception
2. MIT researcher addresses biomedical engineering challenges
3. VaxGen Addresses MPM Claims in Letter to Stockholders
4. Free White Paper Addresses Challenges of New FDA Regulations Awaiting Combo Product Manufacturers
5. Abingworth Appoints David Mayer as Partner
6. Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN
7. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
8. ProMetic provides business update - Over $35 million worth of business secured in January
9. Vermillion Announces First Quarter 2008 Financial Results and Business Progress
10. ThromboGenics N.V. - Business Update
11. MedApps Selected as Dell-NFIB 2008 Business Excellence Award Finalist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Eurofins announces the appointment of Sean Murray ... Scientific Inc. (ESI). Mr. Murray will bring valuable ... entrepreneurial experience in leading international business teams. As the National Division ... to uphold Eurofins, status as the global leader in bio-analytical testing ... , , ...
(Date:12/8/2016)... Oxford Gene Technology (OGT), The Molecular ... with the launch of the SureSeq myPanel™ NGS Custom FH ... familial hypercholesterolemia (FH). The panel delivers single nucleotide variation (SNV) ... panel and allows customisation by ,mix and match, of fully-optimised ... LDLR , P C SK9 , ...
(Date:12/8/2016)... ... December 08, 2016 , ... Microbial genomics leader, uBiome, ... is one of just six company finalists in the Health & Medicine category. ... companies nominated as finalists in this year’s awards include Google, SpaceX, Oculus, and ...
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, ... that discovers, develops and plans to commercialize innovative ... shares of common stock were approved for trading ... begin trading on the OTCQX, effective today, under ... for the OTCQX market, companies must meet high ...
Breaking Biology Technology:
(Date:12/7/2016)... 7, 2016 BioCatch , the global leader ... patent portfolio, which grew to over 40 granted and pending patents. ... , , ... entitled " System, Device, and Method Estimating Force Applied to ... makers to forego costly hardware components needed to estimate the force and ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe , ... BioLock , an electrocardiogram (ECG) biosensor analysis ... a key IoT asset. The smart system ensures ... vehicle,s steering wheel and mobile devices to easily ... As vehicle technology advances, so too ...
Breaking Biology News(10 mins):